TR200202702T2 - Nükleer hormon reseptör fomksiyonun kaynaşmış halkalı modülatörleri. - Google Patents

Nükleer hormon reseptör fomksiyonun kaynaşmış halkalı modülatörleri.

Info

Publication number
TR200202702T2
TR200202702T2 TR2002/02702T TR200202702T TR200202702T2 TR 200202702 T2 TR200202702 T2 TR 200202702T2 TR 2002/02702 T TR2002/02702 T TR 2002/02702T TR 200202702 T TR200202702 T TR 200202702T TR 200202702 T2 TR200202702 T2 TR 200202702T2
Authority
TR
Turkey
Prior art keywords
fused ring
nuclear hormone
hormone receptor
receptor function
ring modulators
Prior art date
Application number
TR2002/02702T
Other languages
Unknown language ( )
English (en)
Turkish (tr)
Inventor
E. Salvati Mark
Aaron Balog James
Shan Weifang
Giese Soren
Original Assignee
Bristol-Myers Squibb Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol-Myers Squibb Company filed Critical Bristol-Myers Squibb Company
Publication of TR200202702T2 publication Critical patent/TR200202702T2/

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/655Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08Bridged systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TR2002/02702T 2000-06-28 2001-06-20 Nükleer hormon reseptör fomksiyonun kaynaşmış halkalı modülatörleri. TR200202702T2 (tr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21439200P 2000-06-28 2000-06-28
US28443801P 2001-04-18 2001-04-18
US28461701P 2001-04-18 2001-04-18

Publications (1)

Publication Number Publication Date
TR200202702T2 true TR200202702T2 (tr) 2004-12-21

Family

ID=27395986

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2002/02702T TR200202702T2 (tr) 2000-06-28 2001-06-20 Nükleer hormon reseptör fomksiyonun kaynaşmış halkalı modülatörleri.

Country Status (9)

Country Link
KR (1) KR20030014407A (zh)
CN (1) CN1443187A (zh)
AR (1) AR031709A1 (zh)
CZ (1) CZ20024250A3 (zh)
IL (1) IL152890A0 (zh)
PE (1) PE20030186A1 (zh)
PL (1) PL366565A1 (zh)
TR (1) TR200202702T2 (zh)
UY (1) UY26809A1 (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9409856B2 (en) 2005-11-28 2016-08-09 Gtx, Inc. Estrogen receptor ligands and methods of use thereof
US8546451B2 (en) 2005-11-28 2013-10-01 Gtx, Inc. Estrogen receptor ligands and methods of use thereof
EA018066B1 (ru) * 2005-11-28 2013-05-30 Джи Ти Икс, ИНК. Агент, связывающийся с ядерными рецепторами
CN102875556B (zh) * 2011-07-12 2016-03-30 天津药明康德新药开发有限公司 (4s)-1-取代-2,5-二氮杂双环[2,2,1]庚烷衍生物及制备方法
CN110184346A (zh) * 2019-07-11 2019-08-30 德阳市人民医院 男性骨质疏松症的诊断标志物

Also Published As

Publication number Publication date
PL366565A1 (en) 2005-02-07
IL152890A0 (en) 2003-06-24
AR031709A1 (es) 2003-10-01
PE20030186A1 (es) 2003-03-23
KR20030014407A (ko) 2003-02-17
UY26809A1 (es) 2002-01-31
CN1443187A (zh) 2003-09-17
CZ20024250A3 (cs) 2003-10-15

Similar Documents

Publication Publication Date Title
MXPA03002412A (es) Compuestos de succinimida heterociclicos fusionados y analogos de los mismos, moduladores de la funcion del receptor de la hormona nuclear.
CY1123783T1 (el) Antiσωμαta enanti-b7-h3 και συζευγματα αντισωματος φαρμακου
DE60230920D1 (de) Kondensierte zyklische modulatoren der funktion von nuklearen hormonrezeptoren
TWI263640B (en) Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
MX2021007368A (es) Anticuerpos anti-receptor de transferrina y usos de los mismos.
BR0111869A (pt) Compostos cìclicos fundidos como moduladores da função do receptor para homÈnio nuclear
AU2002364082A8 (en) Fused heterocyclic compounds and analogs thereof: modulators of nuclear hormone receptor function
AR035977A1 (es) Inmunoconjugados de anticuerpos cd44 citotoxicos.
SV1998000122A (es) Medicamentos ref. pu 3375/sv
DK1135153T3 (da) Anvendelser af EPH-receptorantagonister og -agonister til behandling af vaskulære forstyrrelser
ATE254095T1 (de) Selektive analoge der thyroidhormone
WO2004058717A8 (en) Isoquinolinone derivatives and their use as therapeutic agents
AR052774A1 (es) Inmunoterapia para trastornos autoinmunes
ATE196314T1 (de) Verfahren und zusammensetzungen zur verhinderung von entzündungen und angiogenese enthaltend säugetieren cd97 alpha untereinheit
DK1447414T3 (da) Antagonistpeptider af carcinoembronisk antigen (CEA)
ATE382356T1 (de) Pharmazeutische zusammensetzung enthaltend estetrolderivate und anwendung in der krebsbehandlung
TR200202702T2 (tr) Nükleer hormon reseptör fomksiyonun kaynaşmış halkalı modülatörleri.
TR200101337T2 (tr) Değiştirilmiş salımlı ensülin sensitizörü için farmasötik terkip ve kullanımı.
ATE279923T1 (de) Urotensin-ii rezeptorantagonisten
ECSP024410A (es) Moduladores cilcicos fusionados de la funcion de receptores nucleares hormonales
ATE279198T1 (de) Kombinationen von endometrium schonenden gestagenen und endometrium atrophisierenden gestagenen mit estrogenen, bei der oralen empfängnisverhütung
ES2195002T3 (es) Antagonistas de los receptores de la endotelina.
MX2023006483A (es) Terapia radionuclidica de receptores peptidicos.
WO2002066415A3 (en) Non-steroidal modulators of estrogen receptors
AR036257A1 (es) Sulfamatos de 2-alcoxiestradiol de accion antitumoral